Healthware Group has acquired pharmaphorum in a move that will combine its consulting and full-service agency capabilities with pharmaphorum’s content-driven stakeholder engagement and publ
Sanofi had no sooner announced the departure of David Loew, its head of vaccines, before he surfaced as the new chief executive of French specialty drugmaker Ipsen, taking over
Sanofi and Regeneron’s once close relationship has been become a little more distant over the last couple of years, and the process continued this week after Sanofi said it wil
Prime Global has bought Cambridge Medical Communication in a deal that will see the UK-based company join its stable of six agencies and two consultancies.
Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy Leqembi, saying its efficacy does not outweigh its risks.